Fast Market Research recommends "Hycor Biomedical Inc. - Product Pipeline Analysis, 2014 Update" from GlobalData, now available

Boston, MA -- (SBWire) -- 09/25/2014 --Hycor Biomedical Inc. (Hycor) is an in vitro diagnostics products manufacturer and marketer. The company manufactures and markets systems and testing products for in vitro allergy and autoimmune disorders. Its products include ultra-sensitive EIA system, ELISA microplate assay kits, 288 plus system, reagents, allergy products, urinalysis products, and serology reagents. Hycor provides serology assays for detection of antibodies to target organisms. The company provides organ-specific, systemic, ENA-6 tests, DNA, anti-nuclear cytoplasmic, phospholipid, rheumatoid factor, celiac disease autoantibodies, and bulk reagents and components for autoimmune applications. It markets its products through the brand names such as Hycor and Autostat. The company has operations in Garden Grove, California and Kassel. Hycor is headquartered in Garden Grove, California, the US.

View Full Report Details and Table of Contents

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Hycor Biomedical Inc.

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 800-844-8156

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- Saladax Biomedical, Inc. - Product Pipeline Analysis, 2014 Update
- Beckman Coulter, Inc. - Product Pipeline Analysis, 2014 Update
- Sequenom, Inc. (SQNM) - Product Pipeline Analysis, 2014 Update
- Imperial College London - Product Pipeline Analysis, 2014 Update
- Biotronik SE & Co. KG - Product Pipeline Analysis, 2014 Update
- Qiagen N.V. (QIA) - Product Pipeline Analysis, 2014 Update
- BioTime, Inc. (BTX) - Product Pipeline Analysis, 2014 Update
- Boston Scientific Corporation (BSX) - Product Pipeline Analysis, 2014 Update
- St. Jude Medical, Inc. (STJ) - Product Pipeline Analysis, 2014 Update
- Quidel Corporation (QDEL) - Product Pipeline Analysis, 2014 Update